Brevan Howard Capital Management’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-45,919
Closed -$52.3K 2447
2026
Q1
$52.3K Sell
45,919
-39,429
-46% -$48.5K ﹤0.01% 2082
2025
Q4
$108K Buy
+85,348
New +$119K ﹤0.01% 1672
2025
Q1
Sell
-66,282
Closed -$97.4K 1376
2024
Q4
$97.4K Sell
66,282
-35,972
-35% -$55K ﹤0.01% 968
2024
Q3
$152K Buy
102,254
+65,712
+180% +$97.5K ﹤0.01% 1037
2024
Q2
$45.7K Buy
+36,542
New +$47.4K ﹤0.01% 1009
2023
Q4
Sell
-20,153
Closed -$32.2K 1082
2023
Q3
$32.2K Buy
+20,153
New +$36.7K ﹤0.01% 373

Other funds holding OPK

Brevan Howard Capital Management's OPK Position: Q2 2026 in Review

Brevan Howard Capital Management sold out of Opko Health (OPK) in Q2 2026, closing a stake of 45,919 shares — an estimated $52.3K sold.

Brevan Howard Capital Management first reported a position in OPK in Q3 2023 and held it in 6 quarters. The position peaked at $152K in Q3 2024. 223 funds tracked by Wall St. Rank hold OPK as of Q2 2026.

  • Brevan Howard Capital Management reported no remaining Opko Health position as of Q2 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 45,919 Opko Health shares in Q2 2026, an estimated $52.3K.
  • Brevan Howard Capital Management first reported a position in Opko Health in Q3 2023 and held it in 6 quarters.
  • Brevan Howard Capital Management's Opko Health position peaked at $152K in Q3 2024.
  • 223 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.